Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy
Authors:
- Adam R. GlassmanAGAdam R. Glassman
- Drcr Retina NetworkDNDrcr Retina Network
Open Access
- 6 May 2021
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 139 (7) , 725-733
Abstract
Vitreous hemorrhage is common in patients with proliferative diabetic retinopathy (PDR) and can cause severe vision loss.1 Despite treatment with panretinal photocoagulation (PRP) or intravitreous ranibizumab for PDR, almost half of the eyes in the DRCR Retina Network Protocol S developed vitreous hemorrhage during 5 years of follow-up.2 Although vitreous hemorrhage can clear spontaneously, intervention may hasten visual recovery. Once the clinician and patient decide that intervention for the vitreous hemorrhage is needed, treatment options include injections of anti–vascular endothelial growth factor (anti-VEGF) agents to cause regression of neovascularization while the vitreous hemorrhage is reabsorbed or surgical removal of the vitreous hemorrhage and neovascular membranes with vitrectomy plus PRP.Keywords
This publication has 7 references indexed in Scilit:
- Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic RetinopathyJAMA, 2020
- Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic RetinopathyJAMA Ophthalmology, 2020
- Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic RetinopathyJAMA Ophthalmology, 2018
- Surgery for post-vitrectomy cataractCochrane Database of Systematic Reviews, 2013
- World Medical Association Declaration of HelsinkiJAMA, 2013
- Vitrectomy surgery increases oxygen exposure to the lens: A possible mechanism for nuclear cataract formationAmerican Journal of Ophthalmology, 2005
- Diabetic retinopathyClinical Cornerstone, 2003